Calcium and vitamin D supplementation and cognitive impairment in the Women's health initiative

Journal of the American Geriatrics Society

Volumn 60, Issue 12, 2012, Pages 2197-2205

  Rossom, Rebecca C ^a   Espeland, Mark A ^b   Manson, Joann E ^c   Dysken, Maurice W ^d   Johnson, Karen C ^e   Lane, Dorothy S ^f   Leblanc, Erin S ^g   Lederle, Frank A ^h   Masaki, Kamal H ⁱ   Margolis, Karen L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^e Minneapolis Veterans Affairs Health Care System   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g STONY BROOK UNIVERSITY   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF HAWAII   (United States)

Author keywords

calcium; cognition; dementia; mild cognitive impairment; vitamin D

Indexed keywords

CALCIUM CARBONATE; COLECALCIFEROL; PLACEBO;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; COGNITION; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INCIDENCE; MILD COGNITIVE IMPAIRMENT; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; VITAMIN SUPPLEMENTATION; WOMEN'S HEALTH;

AGED; AGED, 80 AND OVER; CALCIUM CARBONATE; CHOLECALCIFEROL; COGNITION; COGNITION DISORDERS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS;

EID: 84870999536     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12032     Document Type: Article

References (41)

1. Grant WB,. Does vitamin D reduce the risk of dementia? J Alzheimers Dis 2009; 17: 151-159.
2. Moore ME, Piazza A, McCartney Y, et al. Evidence that vitamin D3 reverses age-related inflammatory changes in the rat hippocampus. Biochem Soc Trans 2005; 33: 573-577.
3. Obradovic D, Gronemeyer H, Lutz B, et al. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 2006; 96: 500-509.
4. Stein MS, Scherer SC, Ladd KS, et al. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease. J Alzheimers Dis 2011; 26: 477-484.
5. Annweiler C, Allali G, Allain P, et al. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009; 16: 1083-1089.
6. Fedrizzi L, Carafoli E,. Ca2 + dysfunction in neurodegenerative disorders: Alzheimer's disease. BioFactors 2011; 37: 189-196.
7. Bojarski L, Herms J, Kuznicki J,. Calcium dysregulation in Alzheimer's disease. Neurochem Int 2008; 52: 621-633.
8. Green KN, LaFerla FM,. Linking calcium to Abeta and Alzheimer's disease. Neuron 2008; 59: 190-194.
9. Tilvis RS, Kahonen-Vare MH, Jolkkonen J, et al. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci 2004; 59A: 268-274.
10. Schram MT, Trompet S, Kamper AM, et al. Serum calcium and cognitive function in old age. J Am Geriatr Soc 2007; 55: 1786-1792.
11. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354: 669-683.
12. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354: 684-696.
13. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289: 2651-2662.
14. Shumaker SA, Reboussin BA, Espeland MA, et al. The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998; 19: 604-621.
15. Stefanick ML, Cochrane BB, Hsia J, et al. The Women's Health Initiative postmenopausal hormone trials: Overview and baseline characteristics of participants. Ann Epidemiol 2003; 9 (Suppl): S78-S86.
16. Ritenbaugh C, Patterson RE, Chlebowski RT, et al. The women's health initiative dietary modification trial: overview and baseline characteristics of participants. Ann Epidemiol 2003; 13 (9): Supplement-1.
17. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2947-2958.
18. Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2959-2968.
19. Resnick SM, Coker LH, Maki PM, et al. The Women's Health Initiative Study of Cognitive Aging (WHISCA): A randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials 2004; 1: 440-450.
20. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354: 684-696.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC: American Psychiatric Association, 1994.
22. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39: 1159-1165.
23. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992.
24. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. JAMA 2004; 291: 2947-2958.
25. Teng EL, Chui HC,. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987; 48: 314-318.
26. Wilcock GK, Lilienfeld S, Gaens E,. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial. Galantamine International-1 Study Group. BMJ 2000; 321: 1445-1449.
27. Brunner R, Dunbar-Jacob J, Leboff MS, et al. Predictors of adherence in the Women's Health Initiative Calcium and Vitamin D Trial. Behav Med 2009; 34: 145-155.
28. Burnam MA, Wells KB, Leake B, et al. Development of a brief screening instrument for detecting depressive disorders. Med Care 1988; 26: 775-789.
29. Littell RC, Milliken GA, Stroup WW, et al. SAS System for Mixed Models. Cary, NC: SAS Institute, Inc., 1996.
30. Annweiler C, Schott AM, Allali G, et al. Association of vitamin D deficiency with cognitive impairment in older women: Cross-sectional study. Neurology 2010; 74: 27-32.
31. Llewellyn DJ, Langa KM, Lang IA,. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 2009; 22: 188-195.
32. Buell JS, Scott TM, Dawson-Hughes B, et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009; 64A: 888-895.
33. Lee DM, Tajar A, Ulubaev A, et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 2009; 80: 722-729.
34. Dickens AP, Lang IA, Langa KM, et al. Vitamin D, cognitive dysfunction and dementia in older adults. CNS Drugs 2011; 25: 629-639.
35. Slinin Y, Paudel M, Taylor BC, et al. Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. J Gerontol A Biol Sci Med Sci 2012; 67: 1092-1098.
36. Slinin Y, Paudel ML, Taylor BC, et al. 25-hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 2010; 74: 33-41.
37. Jorde R, Waterloo K, Saleh F, et al. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso Study. J Neurol 2006; 253: 464-470.
38. Annweiler C, Schott AM, Rolland Y, et al. Dietary intake of vitamin D and cognition in older women: A large population-based study. Neurology 2010; 75: 1810-1816.
39. Annweiler C, Rolland Y, Schott AM, et al. Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: A 7-year longitudinal study. Dement Geriatr Cogn Disord 2011; 32: 273-278.
40. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: Meta-analysis. BMJ 2010; 341: c3691.
41. Brot C, Jorgensen NR, Sorensen OH,. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr 1999; 53: 920-926.